OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 2009-01, Vol.53 (1), p.261-263
Hauptverfasser:	LOUIE, Thomas J, EMERY, Judy, KRULICKI, Walter, BYRNE, Brendan, MAH, Manuel
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Bacteroides Bacteroides - drug effects Bacteroides fragilis Biological and medical sciences Clinical Therapeutics Clostridium difficile Clostridium difficile - drug effects Clostridium Infections Clostridium Infections - drug therapy Dose-Response Relationship, Drug Glycosides Glycosides - administration & dosage Glycosides - therapeutic use Humans Medical sciences Pharmacology. Drug treatments Vancomycin - administration & dosage Vancomycin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	263
container_issue	1
container_start_page	261
container_title	Antimicrobial Agents and Chemotherapy
container_volume	53
creator	LOUIE, Thomas J EMERY, Judy KRULICKI, Walter BYRNE, Brendan MAH, Manuel
description	Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC
doi_str_mv	10.1128/AAC.01443-07
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2612159</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66776735</sourcerecordid><originalsourceid>FETCH-LOGICAL-a502t-5be264d8c87994cb7da8d3c9a0a4bfd791f731ecaf01095c571cecf3e653855e3</originalsourceid><addsrcrecordid>eNqFkc1v1DAQxS0EokvhxhnlAhISWfwR2_EFaRsVWKlSkVjO1qxj77pK4sVOoPz3ON1VKQfEaTSen57nzUPoJcFLQmj9frVqlphUFSuxfIQWBKu6FFyJx2iBsRBlVePqDD1L6Qbnniv8FJ2RWnHOKVug2-svm7LGxWXnez_AaFPRdCGN0bd-6ovWO-eN72wBQ1usU_H1ANEPuyK44gLMaGPwrZ2frfG5ttPddBMtjL0dxplrlg9k1oOzZvRheI6eOOiSfXGq5-jbx8tN87m8uv60blZXJXBMx5JvLRVVW5taKlWZrWyhbplRgKHaulYq4iQj1oDD2Tk3XBJjjWNWcFZzbtk5-nDUPUzb3rYmLxWh04foe4i_dACv_54Mfq934YemglDCVRZ4cxKI4ftk06h7n4ztOhhsmJIWQkohGf8vSAmVVCqcwXdH0MSQUrTufhuC9Zypzpnqu0w1lhl_e8Qh9VTfhCkO-WD_Yl89dPtH-BR4Bl6fAEgGOhdhMD7dc5QQojieXRdHbu93-58-Wp1_1wBGc6bJfBz2G_pGwfk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21272790</pqid></control><display><type>article</type><title>OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>LOUIE, Thomas J ; EMERY, Judy ; KRULICKI, Walter ; BYRNE, Brendan ; MAH, Manuel</creator><creatorcontrib>LOUIE, Thomas J ; EMERY, Judy ; KRULICKI, Walter ; BYRNE, Brendan ; MAH, Manuel</creatorcontrib><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC </description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.01443-07</identifier><identifier>PMID: 18955523</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacteroides ; Bacteroides - drug effects ; Bacteroides fragilis ; Biological and medical sciences ; Clinical Therapeutics ; Clostridium difficile ; Clostridium difficile - drug effects ; Clostridium Infections ; Clostridium Infections - drug therapy ; Dose-Response Relationship, Drug ; Glycosides ; Glycosides - administration & dosage ; Glycosides - therapeutic use ; Humans ; Medical sciences ; Pharmacology. Drug treatments ; Vancomycin - administration & dosage ; Vancomycin - therapeutic use</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2009-01, Vol.53 (1), p.261-263</ispartof><rights>2009 INIST-CNRS</rights><rights>Copyright © 2009 American Society for Microbiology</rights><rights>Copyright © 2009, American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a502t-5be264d8c87994cb7da8d3c9a0a4bfd791f731ecaf01095c571cecf3e653855e3</citedby><cites>FETCH-LOGICAL-a502t-5be264d8c87994cb7da8d3c9a0a4bfd791f731ecaf01095c571cecf3e653855e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612159/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612159/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21119509$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18955523$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LOUIE, Thomas J</creatorcontrib><creatorcontrib>EMERY, Judy</creatorcontrib><creatorcontrib>KRULICKI, Walter</creatorcontrib><creatorcontrib>BYRNE, Brendan</creatorcontrib><creatorcontrib>MAH, Manuel</creatorcontrib><title>OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>AAC</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC </description><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacteroides</subject><subject>Bacteroides - drug effects</subject><subject>Bacteroides fragilis</subject><subject>Biological and medical sciences</subject><subject>Clinical Therapeutics</subject><subject>Clostridium difficile</subject><subject>Clostridium difficile - drug effects</subject><subject>Clostridium Infections</subject><subject>Clostridium Infections - drug therapy</subject><subject>Dose-Response Relationship, Drug</subject><subject>Glycosides</subject><subject>Glycosides - administration & dosage</subject><subject>Glycosides - therapeutic use</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Vancomycin - administration & dosage</subject><subject>Vancomycin - therapeutic use</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1v1DAQxS0EokvhxhnlAhISWfwR2_EFaRsVWKlSkVjO1qxj77pK4sVOoPz3ON1VKQfEaTSen57nzUPoJcFLQmj9frVqlphUFSuxfIQWBKu6FFyJx2iBsRBlVePqDD1L6Qbnniv8FJ2RWnHOKVug2-svm7LGxWXnez_AaFPRdCGN0bd-6ovWO-eN72wBQ1usU_H1ANEPuyK44gLMaGPwrZ2frfG5ttPddBMtjL0dxplrlg9k1oOzZvRheI6eOOiSfXGq5-jbx8tN87m8uv60blZXJXBMx5JvLRVVW5taKlWZrWyhbplRgKHaulYq4iQj1oDD2Tk3XBJjjWNWcFZzbtk5-nDUPUzb3rYmLxWh04foe4i_dACv_54Mfq934YemglDCVRZ4cxKI4ftk06h7n4ztOhhsmJIWQkohGf8vSAmVVCqcwXdH0MSQUrTufhuC9Zypzpnqu0w1lhl_e8Qh9VTfhCkO-WD_Yl89dPtH-BR4Bl6fAEgGOhdhMD7dc5QQojieXRdHbu93-58-Wp1_1wBGc6bJfBz2G_pGwfk</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>LOUIE, Thomas J</creator><creator>EMERY, Judy</creator><creator>KRULICKI, Walter</creator><creator>BYRNE, Brendan</creator><creator>MAH, Manuel</creator><general>American Society for Microbiology</general><general>American Society for Microbiology (ASM)</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20090101</creationdate><title>OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection</title><author>LOUIE, Thomas J ; EMERY, Judy ; KRULICKI, Walter ; BYRNE, Brendan ; MAH, Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a502t-5be264d8c87994cb7da8d3c9a0a4bfd791f731ecaf01095c571cecf3e653855e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacteroides</topic><topic>Bacteroides - drug effects</topic><topic>Bacteroides fragilis</topic><topic>Biological and medical sciences</topic><topic>Clinical Therapeutics</topic><topic>Clostridium difficile</topic><topic>Clostridium difficile - drug effects</topic><topic>Clostridium Infections</topic><topic>Clostridium Infections - drug therapy</topic><topic>Dose-Response Relationship, Drug</topic><topic>Glycosides</topic><topic>Glycosides - administration & dosage</topic><topic>Glycosides - therapeutic use</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Vancomycin - administration & dosage</topic><topic>Vancomycin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LOUIE, Thomas J</creatorcontrib><creatorcontrib>EMERY, Judy</creatorcontrib><creatorcontrib>KRULICKI, Walter</creatorcontrib><creatorcontrib>BYRNE, Brendan</creatorcontrib><creatorcontrib>MAH, Manuel</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LOUIE, Thomas J</au><au>EMERY, Judy</au><au>KRULICKI, Walter</au><au>BYRNE, Brendan</au><au>MAH, Manuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>AAC</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2009-01-01</date><risdate>2009</risdate><volume>53</volume><issue>1</issue><spage>261</spage><epage>263</epage><pages>261-263</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC </abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>18955523</pmid><doi>10.1128/AAC.01443-07</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0066-4804
ispartof	Antimicrobial Agents and Chemotherapy, 2009-01, Vol.53 (1), p.261-263
issn	0066-4804 1098-6596
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2612159
source	MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects	Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Bacteroides Bacteroides - drug effects Bacteroides fragilis Biological and medical sciences Clinical Therapeutics Clostridium difficile Clostridium difficile - drug effects Clostridium Infections Clostridium Infections - drug therapy Dose-Response Relationship, Drug Glycosides Glycosides - administration & dosage Glycosides - therapeutic use Humans Medical sciences Pharmacology. Drug treatments Vancomycin - administration & dosage Vancomycin - therapeutic use
title	OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T11%3A18%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=OPT-80%20Eliminates%20Clostridium%20difficile%20and%20Is%20Sparing%20of%20Bacteroides%20Species%20during%20Treatment%20of%20C.%20difficile%20Infection&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=LOUIE,%20Thomas%20J&rft.date=2009-01-01&rft.volume=53&rft.issue=1&rft.spage=261&rft.epage=263&rft.pages=261-263&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.01443-07&rft_dat=%3Cproquest_pubme%3E66776735%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21272790&rft_id=info:pmid/18955523&rfr_iscdi=true